MedTrace Logo

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

NCT00316784 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 704

Last updated 2009-03-20

No results posted yet for this study

Summary

The study objective is the eluciation of the dose-response function in efficacy (and possibly safety) in order to determine an optimal dose with respect to efficacy and safety. The study is designed with three dose levels and one placebo control.

Conditions

  • Osteoarthritis; Knee

Interventions

DRUG

IDEA-033 (and rescue medication)

Sponsors & Collaborators

  • IDEA AG

    lead INDUSTRY

Principal Investigators

  • Gerold Stucki, Prof, MD · department of physical medicine and rehabilitation of universtity Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00316784 on ClinicalTrials.gov